Cite
HARVARD Citation
Maréchal, C. et al. (2018). Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial. Vaccine. 36 (29), pp. 4278-4286. [Online].